| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caloric Restriction | 6 | 2026 | 103 | 1.270 |
Why?
|
| Exercise | 12 | 2026 | 688 | 1.190 |
Why?
|
| Obesity | 13 | 2026 | 1179 | 1.030 |
Why?
|
| Aged | 56 | 2026 | 10637 | 0.900 |
Why?
|
| Cognition | 8 | 2025 | 553 | 0.770 |
Why?
|
| Life Style | 5 | 2025 | 409 | 0.740 |
Why?
|
| Women's Health | 8 | 2025 | 235 | 0.740 |
Why?
|
| Dementia | 5 | 2025 | 247 | 0.730 |
Why?
|
| Neuropsychological Tests | 6 | 2025 | 363 | 0.730 |
Why?
|
| Female | 66 | 2026 | 20375 | 0.710 |
Why?
|
| Geriatric Assessment | 14 | 2021 | 388 | 0.700 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 302 | 0.690 |
Why?
|
| Aged, 80 and over | 33 | 2025 | 4065 | 0.660 |
Why?
|
| Disability Evaluation | 6 | 2019 | 238 | 0.650 |
Why?
|
| Weight Loss | 7 | 2026 | 462 | 0.640 |
Why?
|
| Humans | 73 | 2026 | 32968 | 0.600 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 1152 | 0.580 |
Why?
|
| Aging | 12 | 2021 | 955 | 0.560 |
Why?
|
| Male | 53 | 2026 | 19754 | 0.540 |
Why?
|
| Resistance Training | 4 | 2019 | 79 | 0.460 |
Why?
|
| Motor Activity | 6 | 2016 | 327 | 0.450 |
Why?
|
| Gene Expression | 2 | 2006 | 336 | 0.430 |
Why?
|
| Middle Aged | 33 | 2026 | 12203 | 0.380 |
Why?
|
| Exercise Test | 5 | 2019 | 226 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2026 | 950 | 0.360 |
Why?
|
| Urinary Incontinence | 2 | 2022 | 48 | 0.350 |
Why?
|
| Lung | 1 | 2013 | 268 | 0.350 |
Why?
|
| Energy Metabolism | 4 | 2025 | 163 | 0.340 |
Why?
|
| Risk Factors | 14 | 2025 | 4001 | 0.330 |
Why?
|
| Hip Joint | 2 | 2026 | 64 | 0.320 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 154 | 0.320 |
Why?
|
| Exercise Therapy | 5 | 2022 | 282 | 0.320 |
Why?
|
| Mobility Limitation | 2 | 2025 | 221 | 0.310 |
Why?
|
| United States | 12 | 2025 | 4132 | 0.310 |
Why?
|
| Heart Failure | 4 | 2022 | 761 | 0.310 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 319 | 0.300 |
Why?
|
| Quality of Life | 9 | 2021 | 976 | 0.300 |
Why?
|
| Prospective Studies | 12 | 2022 | 2338 | 0.290 |
Why?
|
| Independent Living | 2 | 2021 | 105 | 0.280 |
Why?
|
| Morphogenesis | 1 | 2008 | 5 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 69 | 0.270 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 45 | 0.270 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 43 | 0.260 |
Why?
|
| Deglutition | 3 | 2012 | 30 | 0.260 |
Why?
|
| Oral Health | 4 | 2011 | 29 | 0.260 |
Why?
|
| Rural Population | 5 | 2013 | 286 | 0.260 |
Why?
|
| Reproducibility of Results | 6 | 2025 | 770 | 0.250 |
Why?
|
| Feasibility Studies | 2 | 2025 | 308 | 0.250 |
Why?
|
| Muscle Strength | 3 | 2019 | 159 | 0.250 |
Why?
|
| Biometry | 1 | 2006 | 13 | 0.240 |
Why?
|
| Proportional Hazards Models | 5 | 2025 | 765 | 0.240 |
Why?
|
| Dietary Proteins | 1 | 2026 | 55 | 0.230 |
Why?
|
| Video Recording | 1 | 2025 | 60 | 0.230 |
Why?
|
| Genital Neoplasms, Female | 1 | 2025 | 27 | 0.230 |
Why?
|
| Computational Biology | 1 | 2005 | 96 | 0.230 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 21 | 0.230 |
Why?
|
| Risk Reduction Behavior | 1 | 2025 | 125 | 0.220 |
Why?
|
| Survivors | 2 | 2016 | 168 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 96 | 0.210 |
Why?
|
| Bone Density | 1 | 2026 | 203 | 0.210 |
Why?
|
| Baroreflex | 1 | 2025 | 86 | 0.210 |
Why?
|
| Signal Transduction | 1 | 2008 | 689 | 0.210 |
Why?
|
| Aorta, Thoracic | 3 | 2021 | 85 | 0.210 |
Why?
|
| Body Mass Index | 6 | 2019 | 909 | 0.210 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 129 | 0.210 |
Why?
|
| Incidence | 4 | 2025 | 1246 | 0.210 |
Why?
|
| Mitochondria | 1 | 2025 | 214 | 0.200 |
Why?
|
| Models, Statistical | 3 | 2013 | 180 | 0.200 |
Why?
|
| Physical Fitness | 3 | 2021 | 133 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1477 | 0.200 |
Why?
|
| Electronic Health Records | 1 | 2025 | 182 | 0.200 |
Why?
|
| Cohort Studies | 9 | 2025 | 1852 | 0.200 |
Why?
|
| Accidental Falls | 1 | 2025 | 221 | 0.190 |
Why?
|
| Prediabetic State | 1 | 2024 | 74 | 0.190 |
Why?
|
| Age Factors | 8 | 2016 | 1202 | 0.190 |
Why?
|
| Time Factors | 9 | 2011 | 2195 | 0.180 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2022 | 66 | 0.180 |
Why?
|
| Tongue | 2 | 2012 | 14 | 0.180 |
Why?
|
| Overweight | 3 | 2026 | 263 | 0.180 |
Why?
|
| Fecal Incontinence | 1 | 2021 | 23 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2025 | 224 | 0.170 |
Why?
|
| Laryngoscopy | 2 | 2011 | 40 | 0.170 |
Why?
|
| Respiratory Aspiration | 2 | 2011 | 21 | 0.170 |
Why?
|
| Muscle Contraction | 2 | 2019 | 113 | 0.160 |
Why?
|
| Brain | 2 | 2025 | 949 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 894 | 0.160 |
Why?
|
| Postmenopause | 1 | 2022 | 427 | 0.160 |
Why?
|
| Blood Glucose | 2 | 2019 | 495 | 0.150 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 1581 | 0.150 |
Why?
|
| Behavior Therapy | 2 | 2022 | 103 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 475 | 0.150 |
Why?
|
| Fatigue | 1 | 2019 | 83 | 0.150 |
Why?
|
| Health Status | 6 | 2016 | 403 | 0.150 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 156 | 0.140 |
Why?
|
| Hand Strength | 4 | 2012 | 102 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2018 | 486 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 107 | 0.140 |
Why?
|
| Diet | 2 | 2011 | 393 | 0.140 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 258 | 0.140 |
Why?
|
| Cause of Death | 1 | 2018 | 240 | 0.130 |
Why?
|
| Inflammation | 2 | 2012 | 542 | 0.130 |
Why?
|
| Ethnic Groups | 2 | 2018 | 474 | 0.130 |
Why?
|
| Nutritional Status | 2 | 2009 | 78 | 0.120 |
Why?
|
| Deglutition Disorders | 3 | 2011 | 52 | 0.120 |
Why?
|
| Adiposity | 2 | 2021 | 199 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2008 | 288 | 0.120 |
Why?
|
| Muscle, Skeletal | 3 | 2019 | 537 | 0.120 |
Why?
|
| Animals | 7 | 2012 | 7599 | 0.120 |
Why?
|
| Genes, Fungal | 2 | 2006 | 4 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 2 | 2025 | 115 | 0.120 |
Why?
|
| Diet Surveys | 3 | 2011 | 55 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2006 | 74 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2025 | 3460 | 0.120 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2015 | 8 | 0.120 |
Why?
|
| Esophageal Motility Disorders | 2 | 2012 | 6 | 0.110 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 126 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2018 | 1469 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 2287 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2015 | 25 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 54 | 0.110 |
Why?
|
| Sleep | 1 | 2015 | 89 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2012 | 18 | 0.110 |
Why?
|
| Health Surveys | 4 | 2016 | 200 | 0.110 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 13 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 24 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 27 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 18 | 0.100 |
Why?
|
| Pericardium | 1 | 2014 | 55 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 1 | 2014 | 65 | 0.100 |
Why?
|
| Movement | 1 | 2014 | 51 | 0.100 |
Why?
|
| Knee Joint | 1 | 2015 | 143 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 49 | 0.100 |
Why?
|
| Body Composition | 4 | 2021 | 391 | 0.100 |
Why?
|
| Algorithms | 2 | 2008 | 517 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2015 | 219 | 0.100 |
Why?
|
| Aorta | 1 | 2014 | 127 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2010 | 126 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2016 | 828 | 0.100 |
Why?
|
| Motor Cortex | 2 | 2014 | 12 | 0.100 |
Why?
|
| Inhalation Exposure | 1 | 2013 | 10 | 0.100 |
Why?
|
| Air Microbiology | 1 | 2013 | 19 | 0.100 |
Why?
|
| Orthomyxoviridae | 1 | 2013 | 15 | 0.100 |
Why?
|
| Food | 2 | 2011 | 43 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 26 | 0.100 |
Why?
|
| Markov Chains | 1 | 2013 | 32 | 0.100 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 9 | 0.100 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 11 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 95 | 0.090 |
Why?
|
| Affect | 1 | 2013 | 70 | 0.090 |
Why?
|
| Levodopa | 1 | 2012 | 15 | 0.090 |
Why?
|
| Executive Function | 2 | 2025 | 57 | 0.090 |
Why?
|
| Reflex | 1 | 2012 | 16 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 190 | 0.090 |
Why?
|
| Eating | 1 | 2013 | 74 | 0.090 |
Why?
|
| Laryngeal Muscles | 1 | 2012 | 17 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2012 | 20 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 102 | 0.090 |
Why?
|
| Dental Health Services | 1 | 2012 | 11 | 0.090 |
Why?
|
| Sex Factors | 5 | 2017 | 684 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 2 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 98 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 543 | 0.090 |
Why?
|
| Gastrointestinal Transit | 1 | 2011 | 4 | 0.090 |
Why?
|
| Esophagus | 1 | 2012 | 25 | 0.090 |
Why?
|
| Prevalence | 3 | 2025 | 1002 | 0.090 |
Why?
|
| Hypocalcemia | 1 | 2011 | 14 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2012 | 138 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 60 | 0.090 |
Why?
|
| Infant Welfare | 1 | 2011 | 3 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2013 | 127 | 0.090 |
Why?
|
| Thyroidectomy | 1 | 2011 | 20 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 47 | 0.090 |
Why?
|
| Phonation | 1 | 2011 | 2 | 0.090 |
Why?
|
| Maternal Welfare | 1 | 2011 | 8 | 0.090 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 14 | 0.090 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 11 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2012 | 79 | 0.090 |
Why?
|
| Cytokines | 1 | 2012 | 247 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 351 | 0.080 |
Why?
|
| Xerostomia | 1 | 2011 | 30 | 0.080 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 8 | 0.080 |
Why?
|
| Stroke | 2 | 2014 | 610 | 0.080 |
Why?
|
| Biostatistics | 1 | 2010 | 8 | 0.080 |
Why?
|
| Stomatognathic Diseases | 1 | 2010 | 5 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 149 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 26 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2010 | 38 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 183 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 1310 | 0.080 |
Why?
|
| Food Preferences | 1 | 2010 | 35 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2010 | 59 | 0.080 |
Why?
|
| Bicycling | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cardiac Output | 1 | 2009 | 34 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 541 | 0.080 |
Why?
|
| Mouth, Edentulous | 1 | 2009 | 4 | 0.080 |
Why?
|
| Nutrition Disorders | 1 | 2009 | 12 | 0.080 |
Why?
|
| Dental Care for Aged | 1 | 2009 | 6 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2009 | 16 | 0.080 |
Why?
|
| Probability | 2 | 2009 | 157 | 0.080 |
Why?
|
| Heart Rate | 2 | 2025 | 345 | 0.080 |
Why?
|
| Psychometrics | 2 | 2025 | 137 | 0.080 |
Why?
|
| Geriatrics | 1 | 2010 | 86 | 0.070 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 15 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2010 | 158 | 0.070 |
Why?
|
| Sepsis | 1 | 2010 | 166 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 762 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 136 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2009 | 108 | 0.070 |
Why?
|
| Capillaries | 1 | 2008 | 23 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2010 | 172 | 0.070 |
Why?
|
| Quadriceps Muscle | 1 | 2008 | 33 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2009 | 151 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2010 | 469 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 173 | 0.070 |
Why?
|
| Health Behavior | 1 | 2009 | 234 | 0.070 |
Why?
|
| Research Design | 2 | 2025 | 334 | 0.060 |
Why?
|
| Comorbidity | 1 | 2009 | 573 | 0.060 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 432 | 0.060 |
Why?
|
| North Carolina | 4 | 2012 | 1550 | 0.060 |
Why?
|
| Genes, Insect | 1 | 2006 | 4 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 32 | 0.060 |
Why?
|
| Ethanol | 1 | 2008 | 191 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 19 | 0.060 |
Why?
|
| Continental Population Groups | 2 | 2018 | 236 | 0.060 |
Why?
|
| Dictyostelium | 1 | 2005 | 1 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2005 | 4 | 0.060 |
Why?
|
| Fungal Proteins | 1 | 2005 | 9 | 0.060 |
Why?
|
| Normal Distribution | 1 | 2005 | 12 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2006 | 94 | 0.060 |
Why?
|
| Drosophila | 1 | 2006 | 35 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 256 | 0.060 |
Why?
|
| Body Weight | 2 | 2021 | 302 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 68 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 392 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2026 | 136 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2025 | 15 | 0.060 |
Why?
|
| Linear Models | 3 | 2012 | 445 | 0.060 |
Why?
|
| tau Proteins | 1 | 2025 | 39 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2025 | 196 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 682 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 114 | 0.060 |
Why?
|
| Software | 1 | 2005 | 128 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2025 | 32 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 512 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2026 | 187 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2026 | 563 | 0.050 |
Why?
|
| Malnutrition | 1 | 2004 | 19 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2024 | 24 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2025 | 243 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 9586 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 566 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 59 | 0.050 |
Why?
|
| Electromyography | 2 | 2014 | 60 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 780 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 97 | 0.050 |
Why?
|
| Hospitalization | 2 | 2022 | 495 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2016 | 467 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 240 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2022 | 20 | 0.050 |
Why?
|
| Hypertension | 1 | 2009 | 983 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3708 | 0.040 |
Why?
|
| Social Isolation | 1 | 2022 | 46 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2004 | 280 | 0.040 |
Why?
|
| Laryngoscopes | 2 | 2011 | 12 | 0.040 |
Why?
|
| Reference Values | 2 | 2011 | 238 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2025 | 867 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2014 | 179 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 292 | 0.040 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1163 | 0.040 |
Why?
|
| Adolescent | 3 | 2013 | 3643 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 880 | 0.040 |
Why?
|
| Logistic Models | 2 | 2012 | 783 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 576 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 790 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2011 | 694 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 436 | 0.040 |
Why?
|
| African Americans | 2 | 2018 | 1425 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 883 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 23 | 0.030 |
Why?
|
| Telemedicine | 1 | 2018 | 118 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 81 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 363 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 183 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 2529 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 110 | 0.030 |
Why?
|
| Young Adult | 2 | 2013 | 2738 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 34 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2015 | 74 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 329 | 0.030 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 6 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2014 | 29 | 0.030 |
Why?
|
| Motor Skills | 1 | 2014 | 15 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2014 | 56 | 0.030 |
Why?
|
| Troponin T | 1 | 2015 | 95 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 162 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2014 | 100 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2014 | 59 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 99 | 0.020 |
Why?
|
| Sneezing | 1 | 2013 | 8 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2013 | 9 | 0.020 |
Why?
|
| Louisiana | 1 | 2013 | 12 | 0.020 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 11 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2014 | 123 | 0.020 |
Why?
|
| Aerosols | 1 | 2013 | 15 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2013 | 49 | 0.020 |
Why?
|
| Cough | 1 | 2013 | 21 | 0.020 |
Why?
|
| Viral Load | 1 | 2013 | 73 | 0.020 |
Why?
|
| Laryngeal Nerves | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cross Infection | 1 | 2013 | 56 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 255 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2012 | 1 | 0.020 |
Why?
|
| Stifle | 1 | 2012 | 2 | 0.020 |
Why?
|
| Oropharynx | 1 | 2012 | 8 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 134 | 0.020 |
Why?
|
| Interleukins | 1 | 2012 | 18 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 36 | 0.020 |
Why?
|
| Manometry | 1 | 2012 | 20 | 0.020 |
Why?
|
| Hindlimb | 1 | 2012 | 52 | 0.020 |
Why?
|
| Viscosity | 1 | 2011 | 23 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 119 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 6 | 0.020 |
Why?
|
| Health Personnel | 1 | 2013 | 131 | 0.020 |
Why?
|
| Tibia | 1 | 2012 | 60 | 0.020 |
Why?
|
| Gait | 1 | 2012 | 140 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 65 | 0.020 |
Why?
|
| Indians, North American | 1 | 2011 | 110 | 0.020 |
Why?
|
| Students | 1 | 2013 | 179 | 0.020 |
Why?
|
| Cartilage, Articular | 1 | 2012 | 75 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 169 | 0.020 |
Why?
|
| Beverages | 1 | 2011 | 19 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2011 | 36 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 4 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 13 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 183 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2011 | 134 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 72 | 0.020 |
Why?
|
| Rural Health | 1 | 2010 | 44 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 116 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 179 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2010 | 70 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 243 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 273 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 72 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 129 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 460 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 85 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2009 | 48 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 50 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 323 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 50 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1282 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2009 | 36 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 499 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 10 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 821 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 308 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 981 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 241 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 212 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 213 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 268 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 197 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 205 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 413 | 0.020 |
Why?
|
| Self Administration | 1 | 2008 | 293 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 531 | 0.020 |
Why?
|
| Child | 1 | 2013 | 2478 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 421 | 0.020 |
Why?
|
| Disinfection | 1 | 2004 | 6 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 77 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 44 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2004 | 57 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 199 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 183 | 0.010 |
Why?
|